The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
Abstract
Sorafenib is the treatment of reference for advanced hepatocellular carcinoma (HCC), the most frequent form of primary liver tumour. The loss of function of the retinoblastoma (Rb) protein is an important event during liver carcinogenesis, but it is unclear whether the Rb status modulates the response of HCC cells to sorafenib. Here, we examined this question in HCC cells with reduced levels of Rb achieved through stable RNA interference. We show that HCC cells with reduced levels of Rb exhibit a two- to threefold increase in cell death induction upon exposure to sorafenib compared with controls. Sorafenib treatment of Balb/c nude mice that received tumour xenografts derived from HCC cells with reduced Rb levels resulted in complete tumour regression in 50% of the animals treated, compared with tumour stabilization in mice that received control cells. We show that, upon exposure to sorafenib, the Rb-negative status of HCC cells promotes the occurrence of ferroptosis, a form of oxidative necrosis. The findings highlight the role of Rb in the response of HCC cells to sorafenib and the regulation of ferroptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the retinoblastoma protein (Rb) was found to suppress ferroptosis in response to sorafenib [30], suggesting that Rb status may aid in selecting ferroptosis-sensitive tumors, at least for sorafenib.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [30]
Citations
Cites
1 retracted
Valencia, A., Sapp, E., Kimm, J. S., McClory, H., Reeves, P., Alexander, J. S., Ansong, K. A., Masso, N., Frosch, M. P., Kegel, K. B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds516 · Cited by 95
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D. P., Wilhelm, S. M., Lynch, M. J., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,539
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Benmaad, I., Caldéraro, J., Bioulac‐Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,522
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 373
Liu, T., Luo, H., Zhang, J., Hu, X., & Zhang, J. (2021) · BMC Cancer · doi:10.1186/s12885-021-08541-w · Cited by 26
Insight into the Double-Edged Role of Ferroptosis in Disease
Zhang, L., Jia, R., Li, H., Yu, H., Ren, K., Jia, S., Li, Y., & Wang, Q. (2021) · Biomolecules · doi:10.3390/biom11121790 · Cited by 26
Ke, S., Wang, C., Su, Z., Lin, S., & Wu, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.897683 · Cited by 26
SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance
Li, T.-Z. (2024) · American Journal of Cancer Research · doi:10.62347/kgcl7357 · Cited by 25
The role of ferroptosis in digestive system cancer (Review)
Song, Y., Hu, Y., Lin, R., Jiang, K., & Wang, B. (2019) · Oncology Letters · doi:10.3892/ol.2019.10568 · Cited by 25
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism
Olivo, E., Chimia, M. L., Ceramella, J., Catalano, A. A., Chiaradonna, F., Sinicropi, M. S., Cuda, G., Iacopetta, D., & Scumaci, D. (2022) · Cells · doi:10.3390/cells11091432 · Cited by 25
Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
Li, L., Wang, X., Xu, H., Liu, X., & Xu, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.947208 · Cited by 25
Rabitha, R., Shivani, S., Yahya, S., & Sudhandiran, G. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i16.2433 · Cited by 24
Guo, C., Peng, J., Cheng, P., Yang, C., Gong, S., Zhang, L., Zhang, T., & Peng, J. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1290234 · Cited by 25
Small molecule probes for cellular death machines
Li, Y., Qian, L., & Yuan, J. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.05.007 · Cited by 23
Sun, Y., He, Y., Tong, J., Liu, D., Zhang, H., He, T., & Bi, Y. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.011 · Cited by 23
Ren, Z., Zhang, X., & Han, J. (2023) · Protein and Peptide Letters · doi:10.2174/0109298665255704230920063254 · Cited by 23
Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC
Zhang, Y., Guo, R., Li, J., & Zhu, L. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02178-z · Cited by 21
Ferroptosis Biology and Implication in Cancers
Qu, C., Peng, Y., & Liu, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.892957 · Cited by 22
LTBP2 Knockdown Promotes Ferroptosis in Gastric Cancer Cells through p62‐Keap1‐Nrf2 Pathway
Wang, T., Zhou, Z., Wang, C., Qin, Y., Wu, L., Hu, B.-L., Jin, Q., Wei, W., & Huang, M. (2022) · BioMed Research International · doi:10.1155/2022/6532253 · Cited by 22
The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge
Zhu, L., Luo, S., Zhu, Y., Tang, S., Li, C., Jin, X., Wu, F.-L., Jiang, H., Wu, L., & Xu, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s385977 · Cited by 21
Deciphering the link: ferroptosis and its role in glioma
Wang, H., Liu, Y., Che, S., Li, X., Tang, D., Lv, S., & Hai, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346585 · Cited by 24
Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential
Lin, C., & Chi, J. (2020) · Oncotarget · doi:10.18632/oncotarget.27749 · Cited by 24
Liu, J., Cui, J., Zhao, S., Wu, M., Wang, J., Zhang, Y., Jin, B., & Wang, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9316847 · Cited by 21
New perspectives on ferroptosis and its role in hepatocellular carcinoma
Cong, T., Luo, Y., Fu, Y. H. H., Liu, Y., Li, Y., & Li, X. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002327 · Cited by 21
Ferroptosis: the vulnerability within a cancer monster
Xie, W., Agarwal, S., & Yu, J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170027 · Cited by 21
Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow
Jing, F., Li, X., Jiang, H., Sun, J., & Guo, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115561 · Cited by 21
Hacıoğlu, C., & Tuncer, C. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03930-7 · Cited by 21
Jiang, Y., Yu, Y., Pan, Z., Wang, Z., & Sun, M. (2024) · Pharmaceuticals · doi:10.3390/ph17070871 · Cited by 21
SPARC regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma
Hua, H.-W., Jiang, H., Jia, L., Jia, Y., Yao, Y., Chen, Y., Jiang, F., Lu, D., Zhou, Q., Jiang, M., et al. (2021) · Cancer Biomarkers · doi:10.3233/cbm-200101 · Cited by 21
Role of ferroptosis inhibitors in the management of diabetes
Krishna Prasad, M., Mohandas, S., & Ramkumar, K. M. (2022) · BioFactors · doi:10.1002/biof.1920 · Cited by 22
Wen, K., Yan, Y., Shi, J., Hu, L., Wang, W., Liao, H., Li, H., Zhu, Y., Mao, K., & Xiao, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.809672 · Cited by 19
Emerging Potential Therapeutic Targets of Ferroptosis in Skeletal Diseases
Liu, X., Wang, T., Wang, W., Liang, X., Mu, Y., Xu, Y., Bai, J., & Geng, D. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3112388 · Cited by 18
Consoli, V., Fallica, A. N., Sorrenti, V., Pittalà, V., & Vanella, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0179 · Cited by 21
Liu, Y., Zhang, M., Huang, Y., Zhang, Y., Chen, Z., Guan, J., Xia, S., & Liao, J. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02599-w · Cited by 23
Targeting ferroptosis as a therapeutic strategy for hepatotoxicity
Hemmati, N., Anoush, M., Kiasari, B. A., & Torkamani, A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102137 · Cited by 19
Antunes, F., Pereira, G. J. S., Saito, R. D. F., Buri, M. V., Gagliardi, M., Bincoletto, C., Chammas, R. J., Fimia, G. M., Piacentini, M., Corazzari, M., et al. (2020) · Cells · doi:10.3390/cells9030640 · Cited by 19
Chen, A., Yu, Z., Ma, N., Lu, X., Zhang, Y., Xu, W., Wang, Y., Xie, J., Qin, Y., Mo, G., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03628-2 · Cited by 18
Liu, B., Liu, L., & Liu, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450487 · Cited by 19
Liu, J., Wang, Y., Meng, H., Yin, Y., Zhu, H., & Ni, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735013 · Cited by 18
Hou, C., Lv, P., Yuan, H.-F., Zhao, L., Wang, Y., Zhang, H., Yang, G., & Zhang, X.-D. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01299-4 · Cited by 17
Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
Yang, J., & Gu, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1283465 · Cited by 19
Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases
Wang, L., Fang, X., Ling, B., Wang, F., Xia, Y., Zhang, W., Zhong, T., & Wang, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1359453 · Cited by 18
The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors
Yang, Y., Bai, L., Liao, W., Feng, M., Zhang, M., Wu, Q., Zhou, K., Wen, F., Lei, W., Zhang, N., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112678 · Cited by 17
Yang, F., Sun, S., Wang, S., Guo, J., Liu, X., Ge, N., & Wang, G. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.1 · Cited by 18
Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma
Liu, R., Cui, H., Li, D., Guo, X., Zhang, Z., Tan, S., & Zhu, X. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s500084 · Cited by 16
Huang, W., Duan, Y., Yang, X., Shang, C., Chen, X., Zhang, H., & Li, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.629868 · Cited by 16
Dai, T., Li, J., Lü, X. C., Ye, L., Yu, H., Zhang, L., Deng, M., Zhu, S., Liu, W., Wang, G., et al. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s319524 · Cited by 16
Pharmacological Targeting of Ferroptosis in Cancer Treatment
Roushandeh, A. M., Roudkenar, M. H., Valashedi, M. R., Nikoo, A., Najafi-Ghalehlou, N., Tomita, K., Kuwahara, Y., & Sato, T. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666211202091523 · Cited by 17
Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy
Maru, D., Hothi, A., Bagariya, C., & Kumar, A. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220211122745 · Cited by 16
Wen, J., Aili, A., Yan, Y. X., Lai, Y., Niu, S., He, S., Zhang, X., Zhang, G., & Li, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.977348 · Cited by 16
Ferroptosis and its emerging role in tumor
Wang, X., Liu, Z., Ma, L., & Yu, H. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.210010 · Cited by 15
Identification of Ferroptosis-Associated Genes in Prostate Cancer by Bioinformatics Analysis
Wo, Q., Liu, Z., & Hu, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.852565 · Cited by 15
Ferroptosis: The functions of Nrf2 in human embryonic stem cells
Abraki, S. B., Karamali, F., & Nasr‐Esfahani, M. H. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110654 · Cited by 16
Identifying the potential genes in alpha synuclein driving ferroptosis of Parkinson’s disease
Wang, M., Li, T., Gao, R. B., Zhang, Y., & Han, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-44124-4 · Cited by 15
Development and validation of a ferroptosis-related prognostic model in pancreatic cancer
Qiu, C., Wang, X., Zheng, Z., Yang, C., Lin, K., Zhang, K., Tu, M., Jiang, K., & Gao, W. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01114-5 · Cited by 15
Liu, J., Zhang, Z., Zhang, W., Meng, L., Wang, J., Lv, Z., Xia, H., Wu, M. Y., Zhang, Y., & Wang, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.791630 · Cited by 16
Zheng, J., Yang, Z.-H., Li, Y., Yang, L., & Yao, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.823491 · Cited by 16
Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
Ma, S., Adzavon, Y. M., Wen, X., Zhao, P., Xie, F., Liu, M., & Ma, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.873029 · Cited by 15
Lian, J., Zhang, C., & Lu, H. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/6284540 · Cited by 15
The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
Schipilliti, F. M., Garajová, I., Rovesti, G., Balsano, R., Piacentini, F., Dominici, M., & Gelsomino, F. (2021) · Pharmaceuticals · doi:10.3390/ph14010043 · Cited by 14
Zhang, Y., Ren, H., Zhang, C., Li, H., Guo, Q., Xu, H., & Cui, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028054 · Cited by 14
Arginase 2 negatively regulates sorafenib-induced cell death by mediating ferroptosis in melanoma
Yu, Y., Ren, Y., Wang, C., Li, Z., Niu, F., Li, Z., Ye, Q., Wang, J., Yuan, Y., Liu, P., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022166 · Cited by 14
Ferroptosis: a new promising target for hepatocellular carcinoma therapy
Xu, Q., Ren, L., Ren, N., Yang, Y., Pan, J., Zheng, Y., & Wang, G. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04893-y · Cited by 14
Programmed cell death and melatonin: A comprehensive review
Rafiyan, M., Reiter, R. J., Manesh, S. M. R., Asemi, R., Sharifi, M., Mohammadi, S., Mansournia, M. A., & Asemi, Z. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01454-4 · Cited by 14
Schaale, D., Laspa, Z., Balmes, A., Sigle, M., Dicenta, V., Hochuli, R., Fu, X., Serafimov, K., Castor, T., Harm, T., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400863rr · Cited by 14
Liu, L., Lai, Y., Zhan, Z., Fu, Q., & Jiang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.911119 · Cited by 14
Identification of a ferroptosis-related lncRNA signature with prognosis for Wilms tumor
Liu, H., Zhang, M., Zhang, T., Shi, M., Lu, W., Yang, S., Cui, Q., & Li, Z. (2021) · Translational Pediatrics · doi:10.21037/tp-21-211 · Cited by 13
Li, X., Xiong, L., Wen, Y., & Zhang, Z. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.774400 · Cited by 14
Targeting ferroptosis with flavonoids for cancer therapy: Mechanisms and opportunities
Gong, G., Zhang, Z., & Zheng, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189528 · Cited by 13
Engineering Iron-Based Nanomaterials for Breast Cancer Therapy Associated with Ferroptosis
Wei, R., Fu, G., Li, Z., Liu, Y., & Xue, M. (2024) · Nanomedicine · doi:10.2217/nnm-2023-0270 · Cited by 12
Potential therapies for HCC involving targeting the ferroptosis pathway
Li, D. (2024) · American Journal of Cancer Research · doi:10.62347/sigp9279 · Cited by 16
Ferroptosis in cancer (Review)
Zeng, L., Liu, X., Geng, C., Gao, X., & Liu, L. (2024) · Oncology Letters · doi:10.3892/ol.2024.14437 · Cited by 13
Therapeutic potential of synthetic and natural iron chelators against ferroptosis
Prabhune, N. M., Ameen, B., & Prabhu, S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03640-4 · Cited by 15
The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends?
Tan, S., Kong, Y., Xian, Y., Gao, P., Xu, Y., Wei, C., Lin, P., Ye, W., Li, Z., & Zhu, X. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.938677 · Cited by 14
Niu, S., Deng, Y., Yang, Y., Wang, J., Fang, C., Zhou, Y., & Dai, H. (2025) · Virulence · doi:10.1080/21505594.2025.2532806 · Cited by 12
Fan, S., Zhang, S., Kong, D., Wang, H., Shi, Y., Wang, Z., & Zheng, H. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220823122942 · Cited by 11
Hu, F., Liu, J., Liu, H., Li, F., Wan, M., Zhang, M., Jiang, Y., & Rao, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700168 · Cited by 11
Ferroptosis and its impact on common diseases
Zou, P., He, Q., Xia, H., & Zhong, W. (2024) · PeerJ · doi:10.7717/peerj.18708 · Cited by 10
Xu, X., Zhou, N., Lan, H., Yang, F., Dong, B., & Zhang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179767 · Cited by 10
Franco-Juárez, E. X., González-Villasana, V., Camacho-Moll, M. E., Rendón-Garlant, L., Ramírez-Flores, P. N., Silva-Ramírez, B., Peñuelas-Urquides, K., Cabello-Ruiz, E. D., Castorena‐Torres, F., & de León, M. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031760 · Cited by 10
[The role of ferroptosis in chronic diseases].
Chen, J., Xiang, Y., Fang, X., Wang, F., & Min, J. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.02.24 · Cited by 11
Yu, X., Zheng, Q., Zhang, M., Zhang, Q., Zhang, S., He, Y., & Guo, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.746696 · Cited by 10
Schut, A. W., Vriends, A. L. M., Sacchetti, A., Timbergen, M. J. M., Alman, B. A., Al‐Jazrawe, M., Grünhagen, D. J., Verhoef, C. K., Sleijfer, S., & Wiemer, E. A. C. (2022) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2022.02.020 · Cited by 10
Xu, K. (2022) · Biochemistry · doi:10.5772/intechopen.104360 · Cited by 9
Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mechanisms
Che, L., Zhu, L., Zhou, L., & Zhou, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189566 · Cited by 13
Xiang, X., Guo, Y. Z., Chen, Z., Zhang, F., Huang, J., & Qin, Y. (2022) · Medicine · doi:10.1097/md.0000000000032558 · Cited by 9
Liu, X., Liu, T., Zhou, Z., Bian, K., Qiu, C., & Zhang, F. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150762 · Cited by 8
Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study
Liu, J., Tang, R., Zheng, J., & Luo, K. (2024) · Discover Oncology · doi:10.1007/s12672-024-01569-x · Cited by 8
Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma
Kusnick, J., Bruneau, A., Tacke, F., & Hammerich, L. (2022) · Immuno · doi:10.3390/immuno2010014 · Cited by 9
Tu, Z., Li, J., Long, X., Wu, L., Zhu, X., & Huang, K. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9408886 · Cited by 8
The advancements in targets for ferroptosis in liver diseases
Xiang, X., Gao, J., Su, D., & Shi, D. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1084479 · Cited by 8
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
Zhang, S., Wang, C., Xia, W., Duan, H., Qian, S., & Shen, H. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s339996 · Cited by 8
Safari, M. H., Rahimzadeh, P., Alaei, E., Alimohammadi, M., Esfandiari, N., Daneshi, S., Malgard, N., Farahani, N., Taheriazam, A., & Hashemi, M. (2025) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2025.102013 · Cited by 8
Yan, D., Wu, Z., & Qi, X. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.02.008 · Cited by 7
Hori, Y., Yoh, T., Nishino, H., Okura, K., Kurimoto, M., Takamatsu, Y., Satoh, M., Nishio, T., Koyama, Y., Ishii, T., et al. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad094 · Cited by 7
Zhang, H., Wang, J., Xiang, X., Xie, C. Z., Lu, X., Guo, H., Sun, Y., Shi, Z., Song, H., Qiu, N., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020249 · Cited by 7
Ge, T., Wang, Y., Han, Y., Bao, X., & Chunfeng, L. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01611-3 · Cited by 7
The function of necroptosis in liver cancer
Tayir, M., Wang, Y., Chu, T., Wang, X., Fan, Y.-Q., Cao, L., Chen, Y.-H., & Wu, D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167828 · Cited by 7
Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis
McPhail, M. J. W., Khorsandi, S. E., Abbott, L., Al-Kadhimi, G., Kane, P., Karani, J. B., O’Grady, J., Heaton, N. D., Bomford, A. B., & Suddle, A. R. (2019) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000583 · Cited by 7
Epigenetic regulation of ferroptosis in gastrointestinal cancers (Review)
Gong, L., Wu, L., Zhao, S., Xiao, S., Chu, X., Zhang, Y., Li, F., Li, S., Yang, H., & Jiang, P. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5534 · Cited by 6
Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential
Liu, J., Liu, R., Miao, J., & He, A. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01142-w · Cited by 7
Yang, L., Chen, Z., Liu, Y., Wang, X., Li, J., & Ye, Q. (2022) · Cancers · doi:10.3390/cancers14174099 · Cited by 6
Harnessing ferroptosis for cancer therapy: Mechanisms and therapeutic strategies (Review)
Mouawad, N., Jaafari, N. E., El‐Sibai, M., & Abi‐Habib, R. J. (2025) · Oncology Reports · doi:10.3892/or.2025.9029 · Cited by 7
Biological protein mediated ferroptotic tumor nanotherapeutics
Tao, J., Li, C., Zheng, Y., Wang, F., Zhang, M., Wu, X., Chen, Y., Zeng, Q., Chen, F., & Fei, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01289d · Cited by 5
Metadata
- Authors
- Louandre, C., Marcq, I., Bouhlal, H., Lachaier, E., Godin, C., Saidak, Z., François, C., Chatelain, D., Debuysscher, V., Barbare, J.-C., Chauffert, B., & Galmiche, A.
- Affiliations
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Université de Picardie Jules Verne (FR)
- Corresponding author
- Galmiche, Antoine
- ORCID
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 356
- Issue
- 2
- Pages
- 971-977
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1966824235
- Cited by
- 374
- References
- 29
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 41 · 2023: 50 · 2022: 76 · 2021: 71 · 2020: 39 · 2019: 21 · 2018: 16 · 2017: 12 · 2016: 7 · 2015: 4
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ligue Contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoblastoma protein, ferroptosis, sorafenib, hepatocellular carcinoma, drug response, tumor regression, RNA interference, tumor xenografts
- MeSH terms
- Sorafenib, Animals, Antineoplastic Agents, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Mice, Inbred BALB C, Mice, Nude, Mitochondria, Necrosis, Niacinamide, Phenylurea Compounds, Tumor Cells, Cultured, Blotting, Western, Retinoblastoma Protein, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Xenograft Model Antitumor Assays, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review